A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in adults in developed countries. CVD encompasses many diseased states, including hypertension, coronary artery disease and atherosclerosis. Studies in animal models and human studies have elucidated the contribution of man...

Full description

Bibliographic Details
Main Authors: Priscilla R. Prestes, Michelle C. Maier, Bradley A. Woods, Fadi J. Charchar
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/10/3666
_version_ 1797567246745206784
author Priscilla R. Prestes
Michelle C. Maier
Bradley A. Woods
Fadi J. Charchar
author_facet Priscilla R. Prestes
Michelle C. Maier
Bradley A. Woods
Fadi J. Charchar
author_sort Priscilla R. Prestes
collection DOAJ
description Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in adults in developed countries. CVD encompasses many diseased states, including hypertension, coronary artery disease and atherosclerosis. Studies in animal models and human studies have elucidated the contribution of many genetic factors, including non-coding RNAs. Non-coding RNAs are RNAs not translated into protein, involved in gene expression regulation post-transcriptionally and implicated in CVD. Of these, circular RNAs (circRNAs) and microRNAs are relevant. CircRNAs are created by the back-splicing of pre-messenger RNA and have been underexplored as contributors to CVD. These circRNAs may also act as biomarkers of human disease, as they can be extracted from whole blood, plasma, saliva and seminal fluid. CircRNAs have recently been implicated in various disease processes, including hypertension and other cardiovascular disease. This review article will explore the promising and emerging roles of circRNAs as potential biomarkers and therapeutic targets in CVD, in particular hypertension.
first_indexed 2024-03-10T19:40:01Z
format Article
id doaj.art-b9b6fec464c848398dac8650db1f00aa
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T19:40:01Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-b9b6fec464c848398dac8650db1f00aa2023-11-20T01:24:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-012110366610.3390/ijms21103666A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular DiseasePriscilla R. Prestes0Michelle C. Maier1Bradley A. Woods2Fadi J. Charchar3School of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, AustraliaSchool of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, AustraliaSchool of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, AustraliaSchool of Health and Life Sciences, Federation University Australia, Ballarat, VIC 3350, AustraliaCardiovascular disease (CVD) is the leading cause of morbidity and mortality in adults in developed countries. CVD encompasses many diseased states, including hypertension, coronary artery disease and atherosclerosis. Studies in animal models and human studies have elucidated the contribution of many genetic factors, including non-coding RNAs. Non-coding RNAs are RNAs not translated into protein, involved in gene expression regulation post-transcriptionally and implicated in CVD. Of these, circular RNAs (circRNAs) and microRNAs are relevant. CircRNAs are created by the back-splicing of pre-messenger RNA and have been underexplored as contributors to CVD. These circRNAs may also act as biomarkers of human disease, as they can be extracted from whole blood, plasma, saliva and seminal fluid. CircRNAs have recently been implicated in various disease processes, including hypertension and other cardiovascular disease. This review article will explore the promising and emerging roles of circRNAs as potential biomarkers and therapeutic targets in CVD, in particular hypertension.https://www.mdpi.com/1422-0067/21/10/3666long non-coding RNAcircular RNAmicroRNAhypertensioncoronary artery diseaseatherosclerosis
spellingShingle Priscilla R. Prestes
Michelle C. Maier
Bradley A. Woods
Fadi J. Charchar
A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
International Journal of Molecular Sciences
long non-coding RNA
circular RNA
microRNA
hypertension
coronary artery disease
atherosclerosis
title A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
title_full A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
title_fullStr A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
title_full_unstemmed A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
title_short A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
title_sort guide to the short long and circular rnas in hypertension and cardiovascular disease
topic long non-coding RNA
circular RNA
microRNA
hypertension
coronary artery disease
atherosclerosis
url https://www.mdpi.com/1422-0067/21/10/3666
work_keys_str_mv AT priscillarprestes aguidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT michellecmaier aguidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT bradleyawoods aguidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT fadijcharchar aguidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT priscillarprestes guidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT michellecmaier guidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT bradleyawoods guidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease
AT fadijcharchar guidetotheshortlongandcircularrnasinhypertensionandcardiovasculardisease